Milk-derived proteins and peptides in clinical trials

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 800-816

  Artym, Jolanta ^a   Zimecki, Michał ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Casein; Clinical trial; Glycomacropeptide; Hyperimmune immunoglobulin concentrate; Lactoperoxidase; Lysozyme; Proline rich polypeptide; TGF ; lactalbumin

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CASEIN; CASEIN HYDROLYSATE; CASEINOMACROPEPTIDE; IMMUNOGLOBULIN; LACTALBUMIN; LACTOPEROXIDASE; MILK PROTEIN; PEPTIDE FRAGMENT;

ADULT; ALZHEIMER DISEASE; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; BABY FOOD; CATTLE; CHEMISTRY; CLINICAL TRIAL (TOPIC); COLOSTRUM; DRUG POTENTIATION; FOOD PRESERVATION; HUMAN; HYPERTENSION; INFANT; INFECTION CONTROL; METHODOLOGY; MILK; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PREMATURITY; XEROSTOMIA;

ADULT; ALZHEIMER DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; CASEINS; CATTLE; CLINICAL TRIALS AS TOPIC; COLOSTRUM; DIABETES MELLITUS, TYPE 2; DRUG SYNERGISM; FOOD PRESERVATION; HUMANS; HYPERTENSION; IMMUNOGLOBULINS; INFANT; INFANT FOOD; INFANT, PREMATURE, DISEASES; INFECTION CONTROL; LACTALBUMIN; LACTOPEROXIDASE; MILK; MILK PROTEINS; NEOPLASMS; PEPTIDE FRAGMENTS; XEROSTOMIA;

EID: 84892585246     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1061635     Document Type: Article

References (119)

1. A service of the U. S. National Institutes of Health: Study of Biotene Oral Balance Gel for oral care in critically-ill mechanically ventilated neonates. http://www.clinicaltrials.gov (15.04.2013)
2. Ait-Oukhatar N., Pérès J. M., Bouhallab S., Neuville D., Bureau F., Bouvard G., Arhan P., Bouglé D.: Bioavailability of caseinophosphopeptide-bound iron. J. Lab. Clin. Med., 2002;140:290-294
3. Al Obaidi A. H.: Role of airway lactoperoxidase in scavenging of hydrogen peroxide damage in asthma. Ann. Thorac. Med., 2007;2:107-110
4. Aliko A., Alushi A., Tafaj A., Isufi R.: Evaluation of the clinical efficacy of biotène oral balance in patients with secondary Sjögren's syndrome: a pilot study. Rheumatol. Int., 2012;32:2877-2881
5. Artym J., Zimecki M.: The role of lactoferrin in the proper development of newborns. Postȩpy Hig. Med. Dośw., 2005;59:421-432
6. Azarpazhooh A., Limeback H.: Clinical efficacy of casein derivatives: a systematic review of the literature. J. Am. Dent. Assoc., 2008;139:915-924
7. Barbana C., Sánchez L., Pérez M. D.: Bioactivity of α-lactalbumin related to its interaction with fatty acids: a review. Crit. Rev. Food Sci. Nutr., 2011;51:783-794
8. Beulens J. W., Bindels J. G., de Graaf C., Alles M. S., Wouters-Wesseling W.: Alpha-lactalbumin combined with a regular diet increases plasma Trp-LNAA ratio. Physiol. Behav., 2004;81:585-593
9. Bilikiewicz A., Gaus W.: Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. J. Alzheimers Dis., 2004;6:17-26
10. Boldogh I., Aguilera-Aguirre L., Bacsi A., Choudhury B. K., Saavedra-Molina A., Kruzel M.: Colostrinin decreases hypersensitivity and allergic responses to common allergens. Int. Arch. Allergy Immunol., 2008;146:298-306
11. Bol'shakova A. M., Medvedeva M. M., Zhuravleva T. P.: Lysozyme in the feeding of premature infants with mixed pathology. Antibiotiki, 1984;29:784-790
12. Booij L., Merens W., Markus C. R., Van der Does A. J.: Diet rich in alpha-lactalbumin improves memory in unmedicated recovered depressed patients and matched controls. J. Psychopharmacol., 2006;20:526-535
13. Bouhallab S., Bouglé D.: Biopeptides of milk: caseinophosphopeptides and mineral bioavailability. Reprod. Nutr. Dev., 2004;44:493-498
14. Brody E. P.: Biological activities of bovine glycomacropeptide. Brit. J. Nutr., 2000;84, Suppl. 1:S39-S46
15. Brück W. M., Redgrave M., Tuohy K. M., Lönnerdal B., Graverholt G., Hernell O., Gibson G. R.: Effects of bovine alpha-lactalbumin and casein glycomacropeptide-enriched infant formulae on faecal microbiota in healthy term infants. J. Pediatr. Gastroenterol. Nutr., 2006;43:673-679
16. Bukharin O. V., Zykova L. S., Tarasenko N. F.: Experimental and clinical study of the use of lysozyme in combination with chemotherapeutic agents. Antibiot. Med. Biotekhnol., 1986;31:917-920
17. Cheng S. C., Wu V. W., Kwong D. L., Ying M. T.: Assessment of post-radiotherapy salivary glands. Br. J. Radiol., 2011;84:393-402
18. Dalbeth N., Ames R., Gamble G. D., Horne A., Wong S., Kuhn-Sherlock B., MacGibbon A., McQueen F. M., Reid I. R., Palmano K.: Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial. Ann. Rheum. Dis., 2012;71:929-934
19. Darewicz M., Dziuba B., Minkiewicz P., Dziuba J.: The preventive potential of milk and colostrum proteins and protein fragments. Food Rev. Int., 2011;27:357-388
20. Day A. S., Whitten K. E., Lemberg D. A., Clarkson C., Vitug-Sales M., Jackson R., Bohane T. D.: Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J. Gastroenterol. Hepatol., 2006;21:1609-1614
21. de Aguilar-Nascimento J. E., Prado Silveira B. R., Dock-Nascimento D. B.: Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial. Nutrition, 2011;27:440-444
22. Douraghi-Zadeh D., Matharu B., Razvi A., Austen B.: The protective effects of the nutraceutical, colostrinin, against Alzheimer's disease, is mediated via prevention of apoptosis in human neurones induced by aggregated beta-amyloid. J. Nutr. Health Aging, 2009;13:522-527
23. Dupont C., Rivero M., Grillon C., Belaroussi N., Kalindjian A., Marin V.: Alpha-lactalbumin-enriched and probiotic-supplemented infant formula in infants with colic: growth and gastrointestinal tolerance. Eur. J. Clin. Nutr., 2010;64:765-767
24. Ebina T.: Prophylaxis of rotavirus gastroenteritis using immunoglobulin. Arch. Virol. Suppl., 1996;12:217-223
25. Eichenberger J. R., Hadorn B., Schmidt B. J.: A semi-elemental diet with low osmolarity and high content of hydrolyzed lactalbumin in the treatment of acute diarrhea in malnourished children. Arq. Gastroenterol., 1984;21:130-135
26. FitzGerald R. J., Murray B. A., Walsh D. J.: Hypotensive peptides from milk proteins. J. Nutr., 2004;134:980S-988S
27. Freedman D. J., Tacket C. O., Delehanty A., Maneval D. R., Nataro J., Crabb J. H.: Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J. Infect. Dis., 1998;177:662-667
28. Frestedt J. L., Zenk J. L., Kuskowski M. A., Ward L. S., Bastian E. D.: A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study. Nutr. Metab. (Lond), 2008;5:8
29. Ga̧sior-Chrzan B.: Clinical trial of lysozyme treatment of crural ulcers in humans. Przegl. Dermatol., 1988;75:435-438
30. Geerts B. F., van Dongen M. G., Flameling B., Moerland M. M., de Kam M. L., Cohen A. F., Romijn J. A., Gerhardt C. C, Kloek J., Burggraaf J.: Hydrolyzed casein decreases postprandial glucose concentrations in T2DM patients irrespective of leucine content. J. Diet. Suppl., 2011;8:280-292
31. Gil-Montoya J. A., Guardia-López I., González-Moles M. A.: Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth - a pilot study. Gerodontology, 2008;25:3-9
32. Glück U.: The antimicrobial effect of lysozyme on nasal mucosa. HNO, 1989;37:207-210
33. Gustafsson L., Leijonhufvud I., Aronsson A., Mossberg A. K., Svanborg C.: Treatment of skin papillomas with topical α-lactalbuminoleic acid. N. Engl. J. Med., 2004;350:2663-2672
34. Hartman C., Berkowitz D., Weiss B., Shaoul R., Levine A., Adiv O. E., Shapira R., Fradkin A., Wilschanski M., Tamir A., Shamir R.: Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease. Isr. Med. Assoc. J., 2008;10:503-507
35. Hay K. D., Morton R. P.: The efficacy of casein phosphoprotein-calcium phosphate complex (DC-CP) [Dentacal] as a mouth moistener in patients with severe xerostomia. N. Z. Dent. J., 2003;99:46-48
36. Hay K. D., Thomson W. M.: A clinical trial of the anticaries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2002;93:271-275
37. Heine W. E., Klein P. D., Reeds P. J.: The importance of alpha-lactalbumin in infant nutrition. J. Nutr., 1991;121:277-283
38. Hirota T., Ohki K., Kawagishi R., Kajimoto Y., Mizuno S., Nakamura Y., Kitakaze M.: Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens. Res., 2007;30:489-496
39. Hulsmann A. R., Raatgeep H. R., den Hollander J. C., Stijnen T., Saxena P. R., Kerrebijn K. F., de Jongste J. C.: Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am. J. Respir. Crit. Care Med., 1994;149:519-525
40. Hursel R., van der Zee L., Westerterp-Plantenga M. S.: Effects of a breakfast yoghurt, with additional total whey protein or caseinomacropeptide- depleted alpha-lactalbumin-enriched whey protein, on diet-induced thermogenesis and appetite suppression. Br. J. Nutr., 2010;103:775-780
41. Inglot A. D., Janusz M., Lisowski J.: Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes. Arch. Immunol. Ther. Exp., 1996;44:215-224
42. Inouye K.: The effects of lysozyme chloride on the immune response of patients with head and neck cancer. Gan No Rinsho, 1987;33:627-632
43. Ishida Y., Shibata Y., Fukuhara I., Yano Y., Takehara I., Kaneko K.: Effect of an excess intake of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro in subjects with normal blood pressure, high-normal blood pressure, or mild hypertension. Biosci. Biotechnol. Biochem., 2011;75:427-433
44. Iwaniak A., Minkiewicz P.: Biologically active peptides derived from proteins - a review. Pol. J. Food Nutr. Sci., 2008;58:289-294
45. Janusz M., Starościk K., Zimecki M., Wieczorek Z., Lisowski J.: Chemical and physical characterization of a proline-rich polypeptide from sheep colostrum. Biochem. J., 1981;199:9-15
46. Jyoti S., Shashikiran N. D., Reddy V. V.: Effect of lactoperoxidase system containing toothpaste on cariogenic bacteria in children with early childhood caries. J. Clin. Pediatr. Dent., 2009;33:299-303
47. Kelleher S. L., Chatterton D., Nielsen K., Lönnerdal B.: Glycomacropeptide and α-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. Am. J. Clin. Nutr., 2003;77:1261-1268
48. Keogh J. B., Clifton P.: The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk. Am. J. Clin. Nutr., 2008;87:1602-1605
49. Keogh J. B., Woonton B. W., Taylor C. M., Janakievski F., Desilva K., Clifton P. M.: Effect of glycomacropeptide fractions on cholecystokinin and food intake. Br. J. Nutr., 2010;104:286-290
50. Kirstilä V., Lenander-Lumikari M., Söderling E., Tenovuo J.: Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia. Acta Odontol. Scand., 1996;54:391-397
51. Kirstilä V., Lenander-Lumikari M., Tenovuo J.: Effects of a lactoperoxidase-system-containing toothpaste on dental plaque and whole saliva in vivo. Acta Odontol. Scand., 1994;52:346-353
52. Kowalczyk A., Botuliński B., Jaworska M., Kierklo A., Pawińska M., Da̧browska E.: Evaluation of the product based on recaldent technology in the treatment of dentin hypersensitivity. Adv. Med. Sci., 2006;51, Suppl 1:40-42
53. Krissansen G. W.: Emerging health properties of whey proteins and their clinical implications. J. Am. Coll. Nutr., 2007;26:713S-723S
54. Kruzel M. L., Janusz M., Lisowski J., Fischleigh R. V., Georgiades J. A.: Towards an understanding of biological role of colostrinin peptides. J. Mol. Neurosci., 2001;17:379-389
55. Laclair C. E., Ney D. M., MacLeod E. L., Etzel M. R.: Purification and use of glycomacropeptide for nutritional management of phenylketonuria. J. Food Sci., 2009;74:E199-E206
56. Lam S. M., Moughan P. J., Awati A., Morton H. R.: The influence of whey protein and glycomacropeptide on satiety in adult humans. Physiol. Behav., 2009;96:162-168
57. Leszek J., Inglot A. D., Janusz M., Byczkiewicz F., Kiejna A., Georgiades J., Lisowski J.: Colostrinin proline-rich polypeptide complex from ovine colostrums - a long-term study of its efficacy in Alzheimer's disease. Med. Sci. Monit., 2002;8:PI93-PI96
58. Leszek J., Inglot A. D., Janusz M., Lisowski J., Krukowska K., Georgiades J. A.: Colostrinin: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Arch. Immunol. Ther. Exp., 1999;47:377-385
59. Lien E. L., Davis A. M., Euler A. R., Multicenter Study Group: Growth and safety in term infants fed reduced-protein formula with added bovine alpha-lactalbumin. J. Pediatr. Gastroenterol. Nutr., 2004;38:170-176
60. Lis J., Orczyk-Pawiłowicz M., Ka̧tnik-Prastowska M.: Białka mleka ludzkiego zaangażowane w procesy immunologiczne. Postȩpy Hig. Med. Dośw., 2013;67:529-547
61. Litwińczuk Z., Barłowska J., Chabuz W., Brodziak A.: Nutritional value and technological suitability of milk from cows of three Polish breeds included in the genetic resources conservation programme. Ann. Anim. Sci., 2012;12:423-432
62. Lönnerdal B.: Bioactive components in breast milk. J. Paediatr. Child Health, 2013;49(Suppl. 1):1-7
63. Lönnerdal B.: Bioactive proteins in human milk: mechanisms of action. J. Pediatr., 2010;156:S26-S30
64. Lönnerdal B.: Nutritional and physiologic significance of human milk proteins. Am. J. Clin. Nutr., 2003;77:1537S-1543S
65. MacLeod E. L., Clayton M. K., van Calcar S. C., Ney D. M.: Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria. Mol. Genet. Metab., 2010;100:303-308
66. Marino R., Torretta S., Capaccio P., Pignataro L., Spadari F.: Different therapeutic strategies for burning mouth syndrome: preliminary data. J. Oral. Pathol. Med., 2010;39:611-616
67. Markus C. R., Jonkman L. M., Lammers J. H., Deutz N. E., Messer M. H., Rigtering N.: Evening intake of α-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am. J. Clin. Nutr., 2005;81:1026-1033
68. Markus C. R., Olivier B., de Haan E. H.: Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am. J. Clin. Nutr., 2002;75:1051-1056
69. Markus C. R., Olivier B., Panhuysen G. E., Van der Gugten J., Alles M. S., Tuiten A., Westenberg H. G., Fekkes D., Koppeschaar H. F., de Haan E. E.: The bovine protein α-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. Am. J. Clin. Nutr., 2000;71:1536-1544
70. Matear D. W., Barbaro J.: Effectiveness of saliva substitute products in the treatment of dry mouth in the elderly: a pilot study. J. R. Soc. Promot. Health, 2005;125:35-41
71. McKenzie H. A.: Alpha-lactalbumins and lysozymes. EXS 75, 1996:365-409
72. McMillan A. S., Tsang C. S., Wong M. C., Kam A. Y.: Efficacy of a novel lubricating system in the management of radiotherapy-related xerostomia. Oral Oncol., 2006;42:842-848
73. Merens W., Booij L., Markus R., Zitman F. G., Onkenhout W., Van der Does A. J.: The effects of a diet enriched with α-lactalbumin on mood and cortisol response in unmedicated recovered depressed subjects and controls. Br. J. Nutr., 2005;94:415-422
74. Mizuno S., Matsuura K., Gotou T., Nishimura S., Kajimoto O., Yabune M., Kajimoto Y., Yamamoto N.: Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br. J. Nutr., 2005;94:84-91
75. Mossberg A. K., Wullt B., Gustafsson L., Månsson W., Ljunggren E., Svanborg C.: Bladder cancers respond to intravesical instillation of HAMLET (human α-lactalbumin made lethal to tumor cells). Int. J. Cancer, 2007;121:1352-1359
76. Nagy K., Urban E., Fazekas O., Thurzo L., Nagy E.: Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer. J. Craniofac. Surg., 2007;18:1157-1164
77. Nakamura T., Mizutani J., Ohki K., Yamada K., Yamamoto N., Takeshi M., Takazawa K.: Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial. Atherosclerosis, 2011;219:298-303
78. Navas López V. M., Blasco Alonso J, Sierra Salinas C., Barco Gálvez A., Vicioso Recio M. I.: Efficacy of exclusive enteral feeding as primary therapy for paediatric Crohn's disease. Ann. Pediatr., 2008;69:506-514
79. Okhuysen P. C., Chappell C. L., Crabb J., Valdez L. M., Douglass E. T., DuPont H. L.: Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin. Infect. Dis., 1998;26:1324-1329
80. Permyakov E. A., Berliner L. J.: α-lactalbumin: structure and function. FEBS Lett., 2000;473:269-274
81. Piasecki E., Inglot A. D., Winiarska M., Krukowska K., Janusz M., Lisowski J.: Coincidence between spontaneous release of interferon and tumor necrosis factor by colostral leukocytes and the production of a colostrinine by human mammary gland after normal delivery. Arch. Immunol. Ther. Exp., 1997;45:109-117
82. Proctor V. A., Cunningham F. E.: The chemistry of lysozyme and its use as a food preservative and a pharmaceutical. Crit. Rev. Food Sci. Nutr., 1988;26:359-395
83. Rautava S., Lu L., Nanthakumar N. N., Dubert-Ferrandon A., Walker W. A.: TGF-β2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NF-κB pathway. J. Pediatr. Gastroenterol. Nutr., 2012;54:630-638
84. Rozé J. C., Barbarot S., Butel M. J., Kapel N., Waligora-Dupriet A. J., De Montgolfier I., Leblanc M., Godon N., Soulaines P., Darmaun D., Rivero M., Dupont C.: An α-lactalbumin-enriched and symbiotic-supplemented v. a standard infant formula: a multicentre, double-blind, randomised trial. Br. J. Nutr., 2012;107:1616-1622
85. Rubio A., Pigneur B., Garnier-Lengliné H., Talbotec C., Schmitz J., Canioni D., Goulet O., Ruemmele F. M.: The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment. Pharmacol. Ther., 2011;33:1332-1339
86. Sack R. B., Castrellon J., Della Sera E., Goepp J., Burns B., Croll J., Tseng P., Reid R., Carrizo H., Santosham M.: Hydrolyzed lactalbumin-based oral rehydration solution for acute diarrhoea in infants. Acta Paediatr., 1994;83:819-824
87. Sandström O., Lönnerdal B., Graverholt G., Hernell O.: Effects of α-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. Am. J. Clin. Nutr., 2008;87:921-928
88. Sári K., Dombi C., Czeglèdy A., Bánóczy J.: Treatment of xerostomia with lactoperoxidase-containing mouth washes and toothpaste. Fogorv. Sz., 1994;87:263-267
89. Sato M., Oe H., Nakano M., Kawasaki H., Hirayama C.: A random controlled study of the prophylactic effect of lysozyme chloride on post-transfusion hepatitis. Hepatogastroenterology, 1981;28:135-138
90. Schmitt J. A., Jorissen B. L., Dye L., Markus C. R., Deutz N. E., Riedel W. J.: Memory function in women with premenstrual complaints and the effect of serotonergic stimulation by acute administration of an alpha-lactalbumin protein. J. Psychopharmacol., 2005;19:375-384
91. Shah N. P.: Effects of milk-derived bioactives: an overview. Br. J. Nutr., 2000;84:S3-S10
92. Shahdad S. A., Taylor C., Barclay S. C., Steen I. N., Preshaw P. M.: A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur. J. Cancer Care, 2005;14:319-326
93. Shin K., Yaegaki K., Murata T., Ii H., Tanaka T., Aoyama I., Yamauchi K., Toida T., Iwatsuki K.: Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial. Clin. Oral Investig., 2011;15:485-493
94. Silva-Hernandez E. R., Nakano T., Ozimek L.: Isolation and analysis of kappa-casein glycomacropeptide from goat sweet whey. J. Agric. Food Chem., 2002;50:2034-2038
95. Starościk K., Janusz M., Zimecki M., Wieczorek Z., Lisowski J.: Immunologically active nonapeptide fragment of a proline-rich polypeptide from ovine colostrum: amino acid sequence and immunoregulatory properties. Mol. Immunol., 1983;20:1277-1282
96. Svensson M., Håkansson A., Mossberg A. K., Linse S., Svanborg C.: Conversion of alpha-lactalbumin to a protein inducing apoptosis. Proc. Natl. Acad. Sci. USA, 2000;97:4221-4226
97. Szaniszlo P., German P., Hajas G., Saenz D. N., Kruzel M., Boldogh I.: New insights into clinical trial for colostrinin in Alzheimer's disease. J. Nutr. Health Aging, 2009;13:235-241
98. Szymlek-Gay E. A., Lönnerdal B., Abrams S. A., Kvistgaard A. S., Domellöf M., Hernell O.: α-Lactalbumin and casein-glycomacropeptide do not affect iron absorption from formula in healthy term infants. J. Nutr., 2012;142:1226-1231
99. Tacket C. O., Binion S. B., Bostwick E., Losonsky G., Roy M. J., Edelman R.: Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am. J. Trop. Med. Hyg., 1992;47:276-283
100. Tacket C. O., Losonsky G., Livio S., Edelman R., Crabb J., Freedman D.: Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal. J. Infect. Dis., 1999;180:2056-2059
101. Tenovuo J.: Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis., 2002;8:23-29
102. Toljanic J. A., Siddiqui A. A., Patterson G. L., Irwin M. E.: An evaluation of a dentifrice containing salivary peroxidase elements for the control of gingival disease in patients with irradiated head and neck cancer. J. Prosthet. Dent., 1996;76:292-296
103. Townsend R. R., McFadden C. B., Ford V., Cadée J. A.: A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am. J. Hypertens., 2004;17:1056-1058
104. Trabulsi J., Capeding R., Lebumfacil J., Ramanujam K., Feng P., McSweeney S., Harris B., DeRusso P.: Effect of an α-lactalbuminenriched infant formula with lower protein on growth. Eur. J. Clin. Nutr., 2011;65:167-174
105. UniProtKB Protein Knowledgebase. http://www.uniprot.org (15.04.2013)
106. van Calcar S. C., MacLeod E. L., Gleason S. T., Etzel M. R., Clayton M. K., Wolff J. A., Ney D. M.: Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids. Am. J. Clin. Nutr., 2009;89:1068-1077
107. van Neerven R. J., Knol E. F., Heck J. M., Savelkoul H. F.: Which factors in raw cow's milk contribute to protection against allergies? J. Allergy Clin. Immunol., 2012;130:853-858
108. van Steenberghe D., Van den Eynde E., Jacobs R., Quirynen M.: Effect of a lactoperoxidase containing toothpaste in radiation-induced xerostomia. Int. Dent. J., 1994;44:133-138
109. Walker G., Cai F., Shen P., Reynolds C., Ward B., Fone C., Honda S., Koganei M., Oda M., Reynolds E.: Increased remineralization of tooth enamel by milk containing added casein phosphopeptide-amorphous calcium phosphate. J. Dairy Res., 2006;73:74-78
110. Warde P., Kroll B., O'Sullivan B., Aslanidis J., Tew-George E., Waldron J., Maxymiw W., Liu F. F., Payne D., Cummings B.: A phase II study of Biotène in the treatment of postradiation xerostomia in patients with head and neck cancer. Support. Care Cancer, 2000;8:203-208
111. Welk A., Meller C., Schubert R., Schwahn C., Kramer A., Below H.: Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test. BMC Microbiol., 2009;9:134
112. Yamamoto N., Akino A., Takano T.: Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 1994;77:917-922
113. Ylitalo S., Uhari M., Rasi S., Pudas J., Leppäluoto J.: Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis. Acta Paediatr., 1998;87:264-267
114. Young S. N., Pihl R. O., Ervin F. R.: The effect of altered tryptophan levels on mood and behavior in normal human males. Clin. Neuropharmacol., 1988;11, Suppl 1:S207-S215
115. Zavaleta N., Kvistgaard A. S., Graverholt G., Respicio G., Guija H., Valencia N., Lönnerdal B.: Efficacy of an MFGM-enriched complementary food in diarrhea, anemia, and micronutrient status in infants. J. Pediatr. Gastroenterol. Nutr., 2011;53:561-568
116. Zenk J. L., Helmer T. R., Kuskowski M. A.: The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double blind, placebo-controlled trial. Curr. Ther. Res., 2002;63:430-442
117. Zimecki M.: A proline-rich polypeptide from ovine colostrum: colostrinin with immunomodulatory activity. Adv. Exp. Med. Biol., 2008;606:241-250
118. Zimecki M., Artym J., Chodaczek G., Kociȩba M., Rybka J., Skórska A., Kruzel M.: Glycomacropeptide protects against experimental endotoxemia and bacteremia in mice. EJPAU, 2006;9:12
119. Zimecki M., Kruzel M. L.: Milk-derived proteins and peptides of potential therapeutic and nutritive value. J. Exp. Ther. Oncol., 2007;6:89-106